World Aids Day
The global challenge of HIV/AIDS remains one of the most pressing public health issues today. According to the latest data from UNAIDS, around 38.4 million people worldwide are living with HIV/AIDS, underlining the need for not only medical intervention but also comprehensive awareness, education, and social change. Despite the significant strides made in treatment and prevention, the confusion surrounding the relationship between HIV and AIDS still persists.
Young people have become influential advocates in the fight against HIV/AIDS. Research from UNICEF shows that youth-led initiatives can lower HIV transmission rates by as much as 45% in targeted communities. These young activists utilize digital platforms and peer-to-peer education to dispel myths, promote safe practices, and foster supportive environments for those affected by HIV/AIDS.
Dr Gowri Kulkarni, an expert in Internal Medicine, explains that while the terms HIV and AIDS are often used interchangeably, they are distinctly different. "HIV (Human Immunodeficiency Virus) is a virus that attacks the immune system, whereas AIDS (Acquired Immunodeficiency Syndrome) is a condition that occurs when HIV severely damages the immune system," she clarifies. To understand the implications of these differences, it's important to explore the fundamental distinctions between the two.
HIV is the virus responsible for attacking the body’s immune system, specifically targeting CD4 cells, which are crucial for the body’s defense against infections. As HIV progresses, it destroys these cells, weakening the immune system over time. If left untreated, this continuous damage can lead to AIDS.
AIDS, on the other hand, is a syndrome, not a virus. Dr Kulkarni further elaborates that AIDS is a collection of symptoms and illnesses that emerge when the immune system is severely compromised due to prolonged HIV infection. It represents the most advanced stage of HIV, and is characterized by very low CD4 counts or the onset of opportunistic infections like tuberculosis, pneumonia, or certain cancers.
A key distinction to remember is that not everyone with HIV will progress to AIDS. Thanks to advancements in medicine, particularly antiretroviral therapy (ART), individuals living with HIV can manage the virus and maintain a healthy immune system for many years, or even decades, without ever developing AIDS. ART works by suppressing the virus to undetectable levels, effectively preventing the damage HIV would otherwise cause to the immune system.
Without treatment, however, HIV progresses through three stages:
- Acute HIV Infection: This stage occurs shortly after transmission and may include symptoms like fever, fatigue, and swollen lymph nodes.
- Chronic HIV Infection: Often asymptomatic or mildly symptomatic, the virus continues to damage the immune system but at a slower rate.
- AIDS: This is the final stage, marked by severe immune damage and the presence of infections that take advantage of the compromised immune defenses.
Another key distinction between HIV and AIDS is the way in which they are transmitted. HIV is highly contagious and can be transmitted through the exchange of bodily fluids such as blood, semen, vaginal fluids, and breast milk. It is primarily spread through unprotected sexual contact, sharing needles, or from mother to child during childbirth or breastfeeding.
AIDS, however, is not transmissible. It is not a disease that can be passed from one person to another. Rather, AIDS is the result of untreated, advanced HIV infection and is a direct consequence of the virus’s damage to the immune system.
HIV and AIDS are diagnosed through different methods. HIV is diagnosed through blood tests or oral swabs that detect the presence of the virus or antibodies produced by the immune system in response to the virus. Early detection of HIV is crucial, as it allows for timely intervention and treatment, which can prevent the virus from progressing to AIDS.
AIDS, on the other hand, is diagnosed using more specific criteria. Dr Kulkarni notes that the diagnosis of AIDS is made when the individual’s CD4 cell count falls below 200 cells/mm³, or when opportunistic infections or certain cancers (such as Kaposi's sarcoma or lymphoma) are detected. Diagnosing AIDS involves a more thorough assessment of the individual’s immune function and overall health, as opposed to just the detection of HIV.
The treatment goals for HIV and AIDS differ significantly, although both involve antiretroviral therapy (ART). For HIV, the primary treatment goal is to suppress the virus to undetectable levels, thus maintaining a strong immune system and preventing further transmission of the virus. People living with HIV can often live long, healthy lives if they adhere to ART.
For individuals diagnosed with AIDS, the treatment plan becomes more complex. While ART remains an essential part of managing the virus, treatment for AIDS also focuses on addressing the opportunistic infections and secondary health complications associated with severe immune suppression. The goal of treatment for AIDS is not only to manage the HIV virus but also to improve the quality of life and extend survival by treating these secondary health issues.
While the medical community has made great strides in managing HIV, the battle to curb its transmission is also a social and cultural issue. Dr Daman Ahuja, a public health expert, highlights that HIV/AIDS awareness and education are vital to reducing transmission rates and supporting those affected by the virus. "Young people, especially, have become key advocates in the fight against HIV/AIDS," says Dr Ahuja. "Research from UNICEF shows that youth-led initiatives can lower HIV transmission rates by as much as 45% in targeted communities."
Additionally, grassroots activism plays a significant role in raising awareness and addressing stigma. As the World Health Organization reports, community-based interventions have been proven to increase HIV testing rates and improve treatment adherence, which are crucial in the fight against the pandemic.
The ultimate goal of organizations like UNAIDS is to eliminate the HIV/AIDS pandemic by 2030. Achieving this requires global collaboration, from medical treatment advancements to public health strategies, education, and advocacy. Dr Kulkarni’s insight underscores the importance of early detection, treatment adherence, and community support in the fight against HIV/AIDS.
Dr Gowri Kulkarni is Head of Medical Operations at MediBuddy and Dr Daman Ahuja, a public health expert and has been associated with Red Ribbon Express Project of NACO between 2007-12.
Credit: AI
What initially seemed like an ordinary flu turned into a life-threatening medical emergency for a 40-year-old man in the UK, who discovered that his kidneys were failing because of a rare autoimmune disease.
Swaroop Kadambari, a financial services lawyer and father of three, initially dismissed his constant exhaustion, fever and nausea as signs of a viral influenza infection. But blood tests revealed that his kidneys were severely damaged.
Further investigations identified a rare condition called anti-glomerular basement membrane disease (anti-GBM disease).
Kadambari’s diagnosis highlights how some autoimmune diseases can cause severe organ damage while presenting with symptoms that may appear common.
According to The Telegraph, Kadambari was 37 when his symptoms first surfaced in 2023. He had started feeling excessively tired, struggled to stay awake in the evenings and found it difficult to maintain his usual exercise routine. His face also became puffy and he experienced prolonged nausea.
When he developed fever and vomiting, he assumed he had the flu. It was his wife, Tanya, who encouraged him to visit his general practitioner (GP).
Blood test results prompted his doctor to send him to hospital immediately. Within three days, doctors diagnosed him with anti-GBM disease.
Anti-glomerular basement membrane disease is a rare autoimmune disorder in which the body's immune system mistakenly produces antibodies that attack the basement membranes of small blood vessels, spoecifically those in the kidneys and lungs.
The glomerular basement membrane is a thin layer of tissue that forms part of the kidney's filtration system. It helps filter waste from the blood while retaining essential proteins and blood cells.
When antibodies attack this membrane, they cause inflammation and damage to the kidney's filtering system, known as glomeruli. This can lead to progressive kidney failure.
The condition can also affect the lungs by damaging small blood vessels in the air sacs, causing bleeding in the lungs.
When anti-GBM disease affects both the kidneys and lungs, it is commonly referred to as Goodpasture syndrome.
Also read: Nick Jonas Opens Up About Living With Type 1 Diabetes For More Than 2 Decades: What Does It Entail
One of the challenges with anti-GBM disease is that its early symptoms can be mistaken for those of common infections. Some warning signs include:
Treatment aims to stop the immune system from producing harmful antibodies and remove those already circulating in the bloodstream.
Kadambari underwent plasmapheresis, a procedure that removes the patient's blood plasma containing harmful antibodies and replaces it with donor plasma. He also received medicines to suppress his immune system and reduce further damage.
Despite undergoing 14 sessions of plasmapheresis over two weeks, his kidney function continued to deteriorate. After six weeks, a kidney biopsy confirmed that his kidneys were no longer functioning, making regular dialysis necessary.
He eventually became eligible for a kidney transplant after receiving rituximab, a medicine that helps combat antibody-producing immune cells.
Kadambari depended on dialysis to survive for the next year. Initially, he received treatment in hospital and later continued it at home with his wife's help.
In May 2024, approximately a year after his first hospitalisation, Tanya donated one of her kidneys to him after being found to be a suitable match.
The transplant allowed him to stop dialysis and return to a more normal routine.
Credit: AI image
Delhi’s disastrous air quality after Diwali sparked concerns due to the numerous health threats it posed. The AQI of the national capital crossed 400 and remained in that vicinity for days that followed. But on Tuesday, as the temperature dropped, the city’s AQI also seemed to improve.
The AQI lowered enough for the Commission for Air Quality Management (CAQM) to revoke GRAP III rules, though it remained in the ‘poor’ category.
The 24-hour average air quality index (AQI) improved for three consecutive days, falling from 400 during and post Diwali to 204, according to the Central Pollution Control Board (CPCB)’s 4pm reading. It marked Delhi’s best air quality in November and the best since October 31 when 24-hour AQI was 117 (moderate).
But the improvement in AQI does not mean that the residents no longer face respiratory risks. Stage I and II restrictions still remain in force, which means Delhi's air quality is still in the 'poor' category. So as the world observes World COPD Day on November 18, we explore why people would still be at chronic obstructive pulmonary disease (COPD) risk despite improving pollution levels.
This year's theme, "Early Diagnosis and Management for a Better Life," focuses on the importance of identifying symptoms and risks before extensive lung damage occurs.
COPD is a chronic lung disease that restricts airflow, making it difficult to breathe. It includes two conditions: chronic bronchitis, which is long-term inflammation of the airways and excess mucus production, and emphysema, in which the tiny air sacs in the lungs become damaged.
While smoking is widely recognised as a major cause of COPD, it is not the only one. According to India’s Ministry of Health, exposure to household cooking smoke, dust, chemical fumes and even respiratory infections during childhood can contribute to it.
According to the World Health Organization (WHO), COPD caused approximately 3.4 million deaths worldwide in 2023, making it the third-leading cause of death globally. Although COPD cannot be cured, early diagnosis, treatment and reducing exposure to risk factors can help slow disease progression.
Cooking with traditional fuels like wood, coal, crop residue and animal dung can release harmful particles and gases into the air. Long-term exposure in poorly ventilated kitchens can damage the respiratory system over time.
People working in construction, mining, agriculture, textile manufacturing and industries involving chemicals may regularly inhale dust, fumes and other respiratory irritants.
Exposure to pollutants like silica, coal dust, cotton dust, welding fumes and industrial chemicals can cause chronic inflammation and damage to the airways.
You do not have to smoke yourself to experience the harmful effects of tobacco. Regular exposure to second-hand cigarette smoke in shared spaces can also irritate the airways and contribute to respiratory inflammation.
The foundations of lung health are established early in life. Severe or frequent respiratory infections during childhood can interfere with normal lung development and prevent children from reaching their full lung capacity.
The WHO identifies early-life diseases like premature birth, poor growth in the womb and repeated childhood respiratory infections as COPD risk factors. Childhood asthma can also increase the risk of developing chronic airflow obstruction in adulthood.
In some people, COPD develops partly because of inherited genetic factors. One example is alpha-1 antitrypsin deficiency, a rare disorder in which the body does not produce enough of a protein that protects lung tissue from damage.
Without adequate protection, lung tissue can become damaged, increasing the risk of emphysema and COPD.
Also read: 91% Of Indian Studies Spanning 50 Years Link Air Pollution To Diabetes, Heart Disease And Cancer
A temporary dip in air pollution levels does not reverse the effects of prolonged exposure to air pollution. Fine particulate matter like PM2.5, can penetrate deep into the lungs and trigger inflammation.
Long-term exposure can contribute to airway damage, worsen existing respiratory issues and increase the risk of developing chronic respiratory diseases.
According to WHO, outdoor air pollution is among the major risk factors for COPD, alongside tobacco smoke and household air pollution.
Reducing exposure to harmful substances is key to preventing COPD. Quitting smoking, avoiding secondhand smoke, switching to cleaner cooking fuels, improving workplace ventilation and using appropriate respiratory protection can help reduce risk.
People with chronic respiratory issues should consult a doctor rather than dismissing breathlessness or a chronic cough as normal.
Credit: AI image
For many people living with chronic conditions, the hardest part of treatment is not understanding what to do, but managing the daily effort required to do it. When a health routine demands multiple pills, frequent injections, and rigid schedules, treatment fatigue quickly sets in.
Over time, complicated routines lead to missed doses, inconsistent control, and growing frustration. This is not a personal shortcoming or a lack of discipline; it is simply what happens when medical care creates too much friction in everyday life.
This challenge is clearly visible in India’s diabetes landscape. Data from the ICMR-INDIAB study revealed that more than 10.1 crore people in India live with diabetes, and another 136 million have prediabetes. Additionally, findings from the National Family Health Survey (NFHS-6) show that elevated blood sugar is rising rapidly across both cities and rural areas.
Despite increased awareness of Type 2 Diabetes, more than 80% of people undergoing treatment continue to have blood sugar levels above the recommended target, as reflected by Glycated Hemoglobin (HbA1c) levels of 7% or higher. HbA1c reflects the average blood sugar levels over the past three months. Type 2 Diabetes is a progressive disease, and as the condition advances, many individuals may eventually require insulin therapy to manage their blood sugar levels.
Also read: World Diabetes Day 2026: Is India's Toxic Air Adding To Its Diabetes Crisis? What Experts Say
A primary contributor to this gap is the delay in starting essential therapies. On average, patients in India wait nearly 8.8 years before starting basal insulin. The hesitation stems from clear concerns: up to 93% of patients report a strong dread of daily needle pricks, while healthcare providers observe that hectic work and family schedules make daily injections difficult to sustain. During these years of delay, unmanaged high blood sugar silently raises the risk of long-term damage to the heart, kidneys, nerves, and eyes.
Across modern medicine, research shows that simpler treatment plans consistently produce better outcomes. In cardiovascular care combining multiple medications into a single once-daily pill significantly improved adherence and reduced hospital visits.
In metabolic health, long-acting, sustained-release tablets replaced the need to remember multiple midday doses. Whenever therapies adapt to human routines rather than forcing individuals to reorganize their days, patients stay on treatment longer and achieve steadier health results.
Also read: Effect of Diabetes on Different Organs: Why the Damage Is Not the Same Everywhere
For over a century, basal insulin had to be administered as a once-daily injection with some cases, twice a day. Today, that clinical approach has shifted. Insulin Icodec, the world’s first once-weekly basal insulin analogue, was engineered specifically around the need for simplicity. Its formulation attaches to a neutral carrier protein - albumin- in the bloodstream, forming an inactive reserve that steadily releases active insulin across seven full days.
This design reduces the basal insulin injection burden seven-fold, cutting injections from 365 a year down to just 52. Administered once a week through a FlexTouch® pen, this simpler routine does not compromise effectiveness. In the global clinical trial program “ONWARDS”, once-weekly insulin icodec demonstrated superior HbA1c reductions and significantly more Time-in-Range compared to standard once-daily basal insulin (glargine U100). Additionally, adults with type 2 diabetes were 49% more likely to reach HbA1c below 7% with insulin icodec without experiencing clinically significant or severe low blood sugar.
Managing diabetes should never feel like a second job. When healthcare becomes less complicated, living well becomes far more achievable. If injection fatigue, busy schedules, or needle anxiety have delayed blood sugar control, simpler medical options now exist. Speaking with a doctor about simplifying daily care is an effective first step toward lasting health.
© $2026 Times Horizon Private Limited